Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.05 per share
-
Shares outstanding
-
95,490,450
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
10,299,547
-
Shares change
-
-530,945
-
Total reported value, excl. options
-
$23,616,856
-
Value change
-
-$1,469,623
-
Number of buys
-
19
-
Number of sells
-
-15
-
Price
-
$2.29
Significant Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q3 2022
46 filings reported holding CLLS - Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share as of Q3 2022.
Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10,299,547 shares
of 95,490,450 outstanding shares and own 11% of the company stock.
Largest 10 shareholders include Long Focus Capital Management, LLC (2,683,633 shares), CREDIT SUISSE AG/ (1,438,255 shares), PRINCIPAL FINANCIAL GROUP INC (1,343,467 shares), BAILLIE GIFFORD & CO (788,837 shares), MILLENNIUM MANAGEMENT LLC (573,841 shares), Capital International Investors (448,804 shares), JANE STREET GROUP, LLC (343,894 shares), BlackRock Inc. (281,701 shares), D. E. Shaw & Co., Inc. (278,327 shares), and STATE STREET CORP (262,368 shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.